Regenerative Medicine Market Analysis, Market Size, In-Depth Insights, Growth and Forecast 2021-2028

Regenerative Medicine Market Outlook 2028

The global regenerative medicine market was valued at US$ 6 Bn in 2020

It is estimated to expand at a CAGR of 10.3% from 2021 to 2028

The global regenerative medicine market is expected to reach the value of US$ 12.9 Bn by the end of 2028

Report Overview: https://www.transparencymarketresearch.com/regenerative-medicines-market.html

Marketing Helps to Increase Visibility and Awareness about Regenerative Medicines

A large pool of elderly worldwide population and the rising instances of external & internal injuries have led to increasing uptake of regenerative medicines, especially for bone & joint injuries. However, this is a relatively new concept, which promotes the human body's natural capacity to heal. Thus, to increase awareness about regenerative medicine, healthcare facilities are investing in advertising & marketing such as setting up standees in hospitals to increase visibility about therapeutics.

Another factor that has served to boost the global regenerative medicine market is the technological progress in biomaterials. Despite such tailwinds, however, the market is yet to reach its full potential, owing to regulatory constraints, complications & infections, and other ethical concerns.

The regenerative medicine market at present is in the nascent stage, and hence has a strong potential to grow in the near future. Hence, many aspiring players are entering the fray and are upping the ante against their well-entrenched counterparts with more effective products. This is also expected to heat up competition in the market for regenerative medicine, which at present is fragmented and requires R&D investment.

Mesenchymal Stem Cells Under Scrutiny for Improving COVID-19 Patient Outcomes

Since healthcare companies are under scrutiny for increasing treatment options for COVID-19 and its variants such as NeoCoV & Omicron, stakeholders in the regenerative medicine market are taking this opportunity to boost their R&D capabilities. Stakeholders are collaborating with experts to increase studies in order to find the best therapeutic approach for the novel infection. This has led to findings in mesenchymal stem cells (MSCs) that help to reduce inflammatory symptoms and protect against cytokine storm which critically contributes to the COVID-19 progression in patients.

Can Market Revenue of Stem Cells Surpass Biomaterials During Forecast Period?

The regenerative medicine market has been broadly divided on the basis of technology into biomaterials, stem cell therapy, and tissue engineering. Of these, the stem cell technology holds maximum potential in the market at present. It is a bio-based alternative that is gaining traction in spite of the swift development of synthetic options. This can be ascribed to the high generative capacity of the stem cells that brings about production of other cells in the body. Not only in bone and joint disorders, regenerative medicine also finds usage in treating retinal diseases, cancer, diabetes, Alzheimer's, rheumatoid arthritis, cerebral palsy, autism spectrum, and others.

Moreover, stem cells are predicted to play a crucial role in regenerative medicine, which serves to treat the primary cause of the ailment, instead of the symptoms unlike other medicines. Many breakthroughs have already been reported in this direction. However, despite all the progress in the domain of the stem cell therapy, the segment of biomaterials accounts for a leading revenue share at present and is expected to retain its dominance.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

U.S. and Asia Pacific Witness Increased R&D Investment in Regenerative Medicines

From a geographical standpoint, North America dominates the regenerative medicine market. This can be attributed to extensive, cutting-edge research and development (R&D) being carried out in the U.S. Large investment allocations by both government and private players are contributing toward the growth of the U.S. regenerative medicine market. Another reason for the dominance of North America is the large elderly population in the region who are highly susceptible to bone & joint issues and the high medical spends of the overall population.

Asia Pacific is another attractive region in the market for regenerative medicine. Numerous factors such as a strengthening healthcare infrastructure, large patient pool due to high population, surging awareness about regenerative medicines, and increasing ability of people to spend on better treatments are playing a key role in promoting market growth in this region. Japan is one of the main markets in this region, owing to fewer regulatory restraints, coupled with technological advancements in the area of regenerative medicine.

Regenerative Medicine Market: Overview

According to Transparency Market Research's latest report on the global regenerative medicine market for the historical period 2017-2018 and forecast period 2021-2028, increase in demand for customized regenerative medicine is projected to drive the global regenerative medicine market during the forecast period

Rise in Prevalence of Chronic Diseases, Genetic Disorders, and Cancer: Key Driver

The incidence and prevalence of chronic diseases such as CVD, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased across the globe

Diabetes and obesity can result in increase in incidence and complexity of wounds such as infections, ulcerations, and surgical wounds, which require treatments and incur exorbitant medical expenses

Beyond established applications in treating multiple myeloma, lymphoma, leukemia, and autoimmune diseases, stem cells derived from adult sources are considered a novel treatment for diverse indications, including cardiovascular, musculoskeletal, endocrine, and neurologic disorders

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=419

Key Players Increased Investment in Research & Development of Regenerative Medicine

Increase in investment by private players and government organizations in the development of regenerative medicine is a major factor boosting the growth of the global market during the forecast period

The field of medicine is constantly developing as newer therapies and medicines are launched in the market. Numerous public-private institutes and companies are focused on conducting studies for developing innovative therapies.

In December 2020, Bayer AG launched a cell and gene therapy platform within its pharmaceutical division. Moreover, growing product pipeline is estimated to fuel market growth during the forecast period.

Costly Treatment Associated with Regenerative Medicine

Cell and gene therapies represent a significant scientific and medical achievement for patients suffering from terminal illnesses and serious disorders. These treatments assist in the transformation of how diseases are treated and possibly cured. Furthermore, such therapies will in future allow doctors and medical professionals to inject genes/cells into patients instead of using a series of medications and undergoing many surgeries.

However, despite the fact that these therapies are lifesavers and more effective than standard treatments, demand for these therapies is lower than anticipated. This is due to high cost of these therapies as well as the difficulties in securing reimbursements and coverage.

Regenerative Medicine Market: Competition Landscape

This report profiles major players in the global regenerative medicine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global regenerative medicine market is highly fragmented due to presence of a number of international as well as regional players

Leading players operating in the global regenerative medicine market are Smith & Nephew plc, Anika Therapeutics, Inc., DePuy Synthes, Inc., Baxter International, Inc., Stryker Corporation, Medtronic, Inc., Arthrex, Inc., Zimmer Holdings, Inc., and CONMED Corporation, among others

Request Customization: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=419

More Trending Reports of Transparency Market Research:

Negative-pressure Wound Therapy (NPWT) Devices Market: https://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html

Laboratory Information Systems Market: https://www.transparencymarketresearch.com/laboratory-information-systems.html

Wound Irrigation Systems Market: https://www.transparencymarketresearch.com/wound-irrigation-systems-market.html

Surgical Navigation Systems Market: https://www.transparencymarketresearch.com/surgical-navigation-systems-market.html

Bioanalytical Testing Services Market: https://www.transparencymarketresearch.com/bioanalytical-testing-services-market.html

Controlled Substance Market: https://www.transparencymarketresearch.com/us-controlled-substance-market.html

Tree Nut Allergy Market: https://www.transparencymarketresearch.com/us-tree-nut-allergy-market.html

Cannabinoids Market: https://www.transparencymarketresearch.com/cannabinoids-market.html

Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Transparency Market Research

Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.